Condition
Beckwith-Wiedemann Syndrome
Total Trials
6
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Recruiting3
Unknown2
Active Not Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT01916148Unknown
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
NCT05945576Recruiting
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
NCT00945009Phase 3Active Not Recruiting
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
NCT01793168Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT06346418Not ApplicableRecruitingPrimary
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks
NCT04993235Unknown
Body Perception and Representation in Overgrowth Syndromes, Behavioral Assessment and Neuropsychological Development
Showing all 6 trials